Cite
HARVARD Citation
Fragaki, M. et al. (2018). Editorial: monitoring vedolizumab trough serum concentration in inflammatory bowel disease—following the fate of anti‐TNF‐alpha agents?. Alimentary pharmacology & therapeutics. 47 (9), pp. 1323-1324. [Online].